An update on Dendritic Cell-Based Cancer Immunotherapy
@article{Shimodaira2016AnUO, title={An update on Dendritic Cell-Based Cancer Immunotherapy}, author={S. Shimodaira and Koichi Hirabayashi and T. Koya and Y. Higuchi and R. Yanagisawa and Masato Okamoto and S. Koido}, journal={Immunome Research}, year={2016}, volume={2016}, pages={1-8} }
Although treating advanced cancers that affect organs with distant metastasis remains challenging, the pace of recent advances has accelerated; these advances have particularly focused on the inhibitors of key immune potentiates. Research on therapeutic vaccination involving active dendritic cell (DC)-based immunotherapy is also being performed for the induction of an effi cient immune response against cancer-associated antigens by the acquired immune system. Cancer vaccines prepared with… CONTINUE READING
3 Citations
References
SHOWING 1-10 OF 73 REFERENCES
Molecular and Translational Classifications of DAMPs in Immunogenic Cell Death
- Medicine
- Front. Immunol.
- 2015
- 204
- PDF
The feasibility and clinical effects of dendritic cell-based immunotherapy targeting synthesized peptides for recurrent ovarian cancer
- Medicine
- Journal of Ovarian Research
- 2014
- 34
Dendritic Cell-Based Immunotherapy Targeting Synthesized Peptides for Advanced Biliary Tract Cancer
- Medicine
- Journal of Gastrointestinal Surgery
- 2013
- 50
Persistent antigen at vaccination sites induces tumor-specific CD8+ T cell sequestration, dysfunction and deletion
- Biology, Medicine
- Nature Medicine
- 2013
- 318
- PDF
Immunotherapy Converts Nonimmunogenic Pancreatic Tumors into Immunogenic Foci of Immune Regulation
- Biology, Medicine
- Cancer Immunology Research
- 2014
- 271
- PDF
Combinatorial treatments including vaccines, chemotherapy and monoclonal antibodies for cancer therapy
- Medicine
- Cancer Immunology, Immunotherapy
- 2008
- 121
- PDF